FiercePharma

Neopharma snatches Dr. Reddy's API plant as it continues global expansion

Just weeks after announcing a deal to sell its antibiotics manufacturing in the U.S. to Neopharma, India’s Dr. Reddy’s Laboratories says it will now unload its API manufacturing business in Jeedimetla ...

Agno Pharma Acquires Actylis’s CDMO Manufacturing Asset, the Legacy Cascade Chemistry Business based in Eugene, Oregon, Strengthening Agno’s US cGMP API D…

Agno Pharma, a global contract development and manufacturing organization (CDMO) specializing in small-molecule active ...

Phlow and Enveda Partner to Advance AI-Driven Chemistry to Accelerate Domestic Pharmaceutical Development and Transform Drug Substance Manufacturing

RICHMOND, Va., January 14, 2026 – Phlow Corp., a leading American pharmaceutical contract development and manufacturing organization (CDMO), today announced a major advancement in AI-driven Active ...
Business Facilities

$6.5B Lilly Expansion Brings API Manufacturing to Texas

Eli Lilly and Company (Lilly) plans to construct an active pharmaceutical ingredient (API) manufacturing facility, totaling around 1 million square feet, in Harris County, Texas. According to news ...
NJBIZ

Cambrex to invest $120M to expand U.S. drug production

“Our customers, in partnership with federal and state agencies, are reshoring drug manufacturing in the U.S., the world’s largest pharmaceutical market. Local API production is vital for supply chain ...
FiercePharma

As API production consolidates abroad, U.S. regulators face safety concerns at home

China and India, which are the largest producers of APIs for the U.S. drug supply, also account for most of the FDA regulatory actions. Not only do quality problems at Chinese and Indian firms raise ...

Sigachi Industries develops new Cystic Fibrosis APIs combination

Sigachi Industries introduces a new Cystic Fibrosis API combination, enhancing its strategic focus on complex specialty ...
PE Hub

PE-backed API to sell its electronic manufacturing services business

MARLBOROUGH, Mass., Nov. 30, 2018 /PRNewswire/ — API Technologies Corp. (“API”), a leading provider of high performance RF and microwave signal conditioning and electromagnetic spectrum management ...
GEN

BMS to Sell Small-Molecule API Manufacturing Facility in Ireland to SK Biotek

Bristol-Myers Squibb (BMS) has agreed to sell its small-molecule active pharmaceutical ingredient (API) manufacturing facility in Swords, Ireland, to Seoul, South Korea-based contract development and ...
Nasdaq

Evotec Announces Sale of API Manufacturing Facility to Monacum Partners

HAMBURG, GERMANY / ACCESSWIRE / November 5, 2024 / Evotec SE (Frankfurt Stock Exchange:EVT)(MDAX/TecDAX, ISIN: DE0005664809)(NASDAQ:EVO) has announced the sale of its chemical API manufacturing site, ...
WBJournal

API sells electronics manufacturing services business for $15M

Marlborough-based API Technologies Corp. has sold its electronics manufacturing services business, API Defense USA, to Norwegian manufacturing firm Kitron for $14.8 million. The business was located ...